ArticleCancer science2026

FB23-2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF/ERCC1 Complex.

Yaoqi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.